Related Experiment Video
Updated: Jan 14, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Improved Impact on Clinical Outcomes and Reduced Cost of Care Associated With Switching Hypoallergenic Amino
Kalpesh H Thakkar1, Pamela Cekola2, Jami Boccella2
1Memorial Hermann Medical Group, Sugar Land, TX, USA.
Abstract:
Amino acid-based formulas (AAF) contain free amino acids as their protein source and are indicated for certain gastrointestinal and medical conditions. When switching formulas, monitoring tolerance helps assure adequate nutritional management. A cross-sectional retrospective study was conducted using U.S. insurance claims data from 402 children switched from one AAF (Formula1) to a different AAF (Formula2) between June 2021 and April 2023 during the nationwide formula shortage. Database was analyzed for age, sex, comorbidities, clinical symptoms, and healthcare encounters. Mean age was 5.3 ± 4.7 years (60% male). Significantly fewer children experienced abdominal distention, diarrhea, flatulence, nausea/vomiting, and allergy symptoms 1-, 3-, 6-months post-switch to Formula2 (P < .05). Significant reductions for total mean adjusted costs, emergency department, inpatient, outpatient, urgent care, and telemedicine visits were observed 1-, 3-, and 6-months post-switch (P < .001). Children in post-acute care settings who transitioned to an alternate AAF (Formula2) experienced significantly improved clinical outcomes and reduced healthcare costs.
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Drug Products: Biologics, Biosimilars and Interchangeables
Allergic Drug Reactions
Bioequivalence: Overview

